Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy in Patients With Major Depressive Disorder
Condition(s):Major Depressive DisorderLast Updated:August 21, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Major Depressive DisorderLast Updated:August 21, 2019Completed
Condition(s):Duchenne Muscular DystrophyLast Updated:September 3, 2020Terminated
Condition(s):AsthmaLast Updated:April 29, 2014Completed
Condition(s):Oculopharyngeal Muscular DystrophyLast Updated:October 17, 2017Completed
Condition(s):Rheumatoid ArthritisLast Updated:November 1, 2015Completed
Condition(s):Crohn’s DiseaseLast Updated:November 5, 2015Withdrawn
Condition(s):Postmenopausal OsteoporosisLast Updated:February 3, 2022Completed
Condition(s):Healthy VolunteersLast Updated:February 5, 2024Recruiting
Condition(s):Alzheimer’s DiseaseLast Updated:March 17, 2020Completed
Condition(s):Spinal Muscular Atrophy; Spinal Muscular Atrophy Type II; Spinal Muscular Atrophy Type 3Last Updated:November 13, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.